首页> 外国专利> Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof

Glycopeptide Compounds Having Activity Of Resisting Drug-Resistant Bacteria, And Preparation Method And Application Thereof

机译:具有抗性耐药细菌的活性的糖肽化合物,以及其制备方法和应用

摘要

The present invention discloses glycopeptide compounds having activity of resisting drug-resistant bacteria, conforming to glycopeptide compounds represented by general formula (I),; embedded image ;The present invention also provides a preparation method for and an application of the glycopeptide compounds. Upon testing, compared with a second-generation glycopeptide drug oritavancin, the glycopeptide antibiotic compounds have higher inhibition activity on drug-resistant bacterial strains, especially MRSA or VRE. Further testing shows that most of the glycopeptide compounds have safety higher than that of oritavancin and can be prepared into drugs for treating or preventing diseases caused by various bacterial infections, such as skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.
机译:本发明公开了具有抗耐药细菌的活性的糖肽化合物,符合通式(I)所示的糖肽化合物,; <化学ID =“Chem-US-00001”> “嵌入图像”文件=“US20210093691A1-20210401-C00001.GIF”他=“61.81mm”IMGContent ;本发明还提供了糖肽化合物的制备方法和应用。在测试后,与第二代糖肽药物Oritavancin相比,糖肽抗生素化合物对耐药细菌菌株的抑制活性较高,尤其是MRSA或VRE。进一步的测试表明,大多数糖肽化合物的安全性高于Oritavancin的安全性,并且可以制备用于治疗或预防由各种细菌感染引起的疾病的药物,例如皮肤和软组织感染,脑膜炎,败血症,肺炎,关节炎,腹膜炎,支气管炎和脓胸。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号